Delivery Order SPE2DR25D1202-SPE2DR26F74GH
- Not listed
- The Defense Logistics Agency awarded a $1,913.65 delivery order to AmerisourceBergen Drug Corp for INFANRIX DTAP vaccine syringes (0.5mL) with a completion date of August 1, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Infanrix DTAP Syringe 0.5ML, a pediatric vaccine product, with a contract value of $1,391.22. The award was made on August 19, 2025, with an ultimate completion date of August 20, 2025, under a firm fixed-price delivery order contract type with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,023.35 to AmerisourceBergen Drug Corp for INFANRIX DTAP SYRINGE 0.5ML, a diphtheria, tetanus, and pertussis vaccine product. The contract is a firm fixed-price delivery order with an ultimate completion date of October 30, 2025, and was awarded on October 29, 2025. This award represents a non-set-aside competitive contract, with performance to be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of INFANRIX DTAP Syringe 0.5mL, a pediatric diphtheria, tetanus, and acellular pertussis vaccine. This firm fixed-price delivery order, valued at $3,091.60, represents a small-value pharmaceutical procurement supporting military and federal healthcare systems. The award is non-competitive and utilizes no set-aside designation, indicating fulfillment through an existing contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $1,228.08 firm fixed-price delivery order by the Defense Logistics Agency on September 25, 2025, for INFANRIX DTAP Syringe 0.5ML, with an ultimate completion date of September 26, 2025. This award was not designated as a set-aside contract and was competitively awarded. The delivery order will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania, and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,503.70 to AmerisourceBergen Drug Corp for the supply of Infanrix DTaP syringes (0.5mL) under a firm fixed price contract. The award was issued on November 6, 2025, with an ultimate completion date of November 7, 2025, and carries no set-aside designation. Performance will take place in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a competitive award...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Infanrix DTAP syringes (0.5 mL) with a ceiling value of $7,231.10. This is a firm fixed-price delivery order with no set-aside designation, indicating the contract was competitively awarded. The order is scheduled for ultimate completion by September 26, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a major pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,036.15 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the supply of INFANRIX DTAP SYRINGE 0.5ML, a pediatric vaccine product, with a period of performance through April 10, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,430.70 for INFANRIX DTAP syringe 0.5ML, a standard diphtheria, tetanus, and acellular pertussis vaccine product. The award was made on November 26, 2025, with an ultimate completion date of November 28, 2025, under a firm fixed-price delivery order contract type with no set-aside designation. The contract will be performed at the awardee's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,918.05 to AmerisourceBergen Drug Corp for INFANRIX DTAP Syringe 0.5ML on December 26, 2025, with completion expected by December 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, executed competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The place of performance is...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F74GHDelivery Order
The Defense Logistics Agency awarded a $1,837.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for Infanrix DTaP vaccine in 0.5 mL syringe format. This is a non-set-aside competitive award with performance location in Conshohocken, Pennsylvania, and an ultimate completion date of January 23, 2026. The delivery order represents a single task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, operates as a subsidiary of its parent company Cencora, Inc. (doing business as AmerisourceBergen). The company maintains a significant contract portfolio with the Defense Logistics Agency covering a comprehensive range of medications, vaccines, and medical supplies across multiple therapeutic domains. This particular vaccine delivery order aligns with the Department of Defense's medical supply chain requirements and supports military treatment facilities and healthcare systems worldwide through the company's established framework as a critical federal medical procurement vendor.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 1/21/26 |